A rising incidence of hypersensitivity reactions associated with oxaliplatin has been noted. Previous reports described predominantly type I allergic reactions, occurring after a median of seven to nine cycles [1] [2] [3] and mostly within minutes following infusion initiation [2] . Our patient, however, developed severe symptoms nearly 24 h after the first infusion. This delay in appearance of these symptoms is a new observation and has not been described earlier. Although we considered acute laryngo-pharyngeal dysesthesia as an explanation for her symptoms, the stridor and cyanosis indicated true laryngospasm. Since re-challenge induced an identical clinical reaction, a clear relation appears to be established. In our view, there is no other explanation for the acute respiratory complication in our patient than an oxaliplatin-related reaction.
Physicians treating patients with oxaliplatin should be aware of this delayed respiratory complication. Prompt symptomatic treatment leads to reversal of symptoms. Given the extreme rareness of this delayed side-effect, clinical monitoring for 24 h of all patients treated with oxaliplatin is not strictly mandatory. 
